C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The proposed demerger is the most significant corporate change for GSK in the last 20 years
The curriculum has been curated for General Physicians working in Clinikk
Boehringer Ingelheim continues to innovate to enhance the customer experience and improve animal health and well-being
ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Business EPS of €1.94, up 20.5% on a reported basis and 16.1% at CER, also benefitting from an improved effective tax rate
Designed to give instant insights on blood sugar, in-depth nutrition and wellness, this programme provides fitness assessments, personalisation and reports for doctors
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
Subscribe To Our Newsletter & Stay Updated